Stifel Financial Corp.: BMO cuts target price to $75 from $85
SF•BMO cut its target price for Stifel Financial Corp. to $75 from $85.
Related News
Galectin Therapeutics submits FDA registrational Phase 3 protocol for belapectin in MASH cirrhosis
GALT•
Stoke Therapeutics completes dosing in first two cohorts of Phase 1 OSPREY trial for STK-002 in optic atrophy
STOK•
Charles River partners with Autolomous to roll out Apollo Orchestrate lab execution system
CRL•
Uber to buy ezCater in $2.3 billion deal
UBER•
Genius Group targets $827 million Bitcoin, $800 million AI asset buildout by FY2031 under dual treasury plan
GNS•